Here is a very interesting article about the man behind Alimta, the first FDA approved drug for mesothelioma treatment. “His find became tumors’ nemesis”
This article highlights and confirms our need to continue to grow the Mesothelioma Applied Research Foundation’s Research Grant Program. Through our proven peer-review process, we are able to identify the best possible projects and disperse funds quickly and efficiently. Most recently, the fruits of our labor have become increasingly evident, as more clinical trials based on our basic lab funding are becoming available to mesothelioma patients. We are relying on your generous contributions to help us achieve the progress needed to help mesothelioma patients today. To contribute, please contact our office at (877) 363-6376 (END-MESO) or visit our donation page.